SEC charges former Pfizer statistician with insider trading over Covid drug trial results

The U.S. Securities and Exchange Commission charged a former Pfizer statistician with insider trading Thursday, stating that the former employee and his friend used inside information about the success of the Covid drug Paxlovid to buy stocks before the company released trial results.

https://www.crainsnewyork.com/health-care/sec-charges-former-pfizer-statistician-insider-trading-over-covid-drug-trial-results